Madrigal Pharmaceuticals Inc (NASDAQ:MDGL)

119.43
Delayed Data
As of 12:29pm ET
 +0.43 / +0.36%
Today’s Change
13.09
Today|||52-Week Range
154.75
+30.11%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line-6.0M-8.3M-8.4M-8.4M
 
 
 
 
 
Depreciation----9.0K60.0K
 
 
 
Total Other Cash Flow602.0K676.0K1.0M947.0K
 
 
 
 
 
Funds From Operations-5.4M-7.7M-7.3M-7.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.6M-13.0K-2.4M-1.5M
 
 
 
 
 
Net Cash Flow - Operating Activities-3.8M-7.7M-5.0M-5.9M
 
 
 
 
 
 
InvestingIncrease In Investments-22.1M-9.0M-3.8M-35.3M
 
 
 
 
 
Decrease In Investments11.6M8.5M-13.1M41.4M
 
 
 
 
 
Capital Expenditures-2.0K-123.0K0.000.00
 
 
 
Net Cash Flow Investing-10.6M-647.0K-16.9M6.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale3.4M34.9M0.00135.5M
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.00----
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing3.4M34.9M0.00135.5M
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-10.9M26.6M-21.8M135.7M